Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 56351 - 56375 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Panobinostat	Approved Investigational	LYN	4067	upregulated	panobinostat results in increased expression of LYN mRNA	8q12.1	A21037
Panobinostat	Approved Investigational	LYPD3	27076	upregulated	panobinostat results in increased expression of LYPD3 mRNA	19q13.31	A21037
Panobinostat	Approved Investigational	LYSMD2	256586	upregulated	panobinostat results in increased expression of LYSMD2 mRNA	15q21.2	A21037
Panobinostat	Approved Investigational	LYZL6	57151	upregulated	panobinostat results in increased expression of LYZL6 mRNA	17q12	A21037
Panobinostat	Approved Investigational	LZTS1	11178	upregulated	panobinostat results in increased expression of LZTS1 mRNA	8p21.3	A21037
Panobinostat	Approved Investigational	MAATS1	89876	downregulated	panobinostat results in decreased expression of MAATS1 mRNA	3q13.33	A21037
Panobinostat	Approved Investigational	MAB21L2	10586	downregulated	panobinostat results in decreased expression of MAB21L2 mRNA	4q31.3	A21037
Panobinostat	Approved Investigational	MACC1	346389	upregulated	panobinostat results in increased expression of MACC1 mRNA	7p21.1	A21037
Panobinostat	Approved Investigational	MACROD2	140733	downregulated	panobinostat results in decreased expression of MACROD2 mRNA	20p12.1	A21037
Panobinostat	Approved Investigational	MAFB	9935	upregulated	panobinostat results in increased expression of MAFB mRNA	20q12	A21037
Panobinostat	Approved Investigational	MAGI2	9863	upregulated	panobinostat results in increased expression of MAGI2 mRNA	7q21.11	A21037
Panobinostat	Approved Investigational	MAK	4117	downregulated	panobinostat results in decreased expression of MAK mRNA	6p24.2	A21037
Panobinostat	Approved Investigational	MAN1A1	4121	upregulated	panobinostat results in increased expression of MAN1A1 mRNA	6q22.31	A21037
Panobinostat	Approved Investigational	MANEAL	149175	upregulated	panobinostat results in increased expression of MANEAL mRNA	1p34.3	A21037
Panobinostat	Approved Investigational	MAP1LC3C	440738	upregulated	panobinostat results in increased expression of MAP1LC3C mRNA	1q43	A21037
Panobinostat	Approved Investigational	MAP2	4133	upregulated	panobinostat results in increased expression of MAP2 mRNA	2q34	A21037
Panobinostat	Approved Investigational	MAP6	4135	downregulated	panobinostat results in decreased expression of MAP6 mRNA	11q13.5	A21037
Panobinostat	Approved Investigational	MAPK10	5602	downregulated	panobinostat results in decreased expression of MAPK10 mRNA	4q21.3	A21037
Panobinostat	Approved Investigational	MAPK13	5603	upregulated	panobinostat results in increased expression of MAPK13 mRNA	6p21.31	A21037
Panobinostat	Approved Investigational	MARC2	54996	upregulated	panobinostat results in increased expression of MARC2 mRNA	1q41	A21037
Panobinostat	Approved Investigational	MBNL3	55796	upregulated	panobinostat results in increased expression of MBNL3 mRNA	Xq26.2	A21037
Panobinostat	Approved Investigational	MBOAT1	154141	upregulated	panobinostat results in increased expression of MBOAT1 mRNA	6p22.3	A21037
Panobinostat	Approved Investigational	MCC	4163	upregulated	panobinostat results in increased expression of MCC mRNA	5q22.2	A21037
Panobinostat	Approved Investigational	MCOLN3	55283	upregulated	panobinostat results in increased expression of MCOLN3 mRNA	1p22.3	A21037
Panobinostat	Approved Investigational	MCUB	55013	downregulated	panobinostat results in decreased expression of MCUB mRNA	4q25	A21037

Displaying entries 56351 - 56375 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability